These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16102092)

  • 21. Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor.
    Casonato A; Pontara E; Sartorello F; Gemmati D; Cattini MG; Girolami A
    Haematologica; 2001 Oct; 86(10):1110-1. PubMed ID: 11602423
    [No Abstract]   [Full Text] [Related]  

  • 22. The D' domain of von Willebrand factor requires the presence of the D3 domain for optimal factor VIII binding.
    Przeradzka MA; Meems H; van der Zwaan C; Ebberink EHTM; van den Biggelaar M; Mertens K; Meijer AB
    Biochem J; 2018 Sep; 475(17):2819-2830. PubMed ID: 30111575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
    Kroner PA; Foster PA; Fahs SA; Montgomery RR
    Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
    Brinkhous KM; Sandberg H; Garris JB; Mattsson C; Palm M; Griggs T; Read MS
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8752-6. PubMed ID: 3936044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand factor containing factor VIII concentrates.
    Berntorp E
    Haemophilia; 1999 May; 5 Suppl 2():60-3. PubMed ID: 23401902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 27. Interactions between von Willebrand factor and Factor VIII: where did they first meet.
    Montgomery RR; Gill JC
    J Pediatr Hematol Oncol; 2000; 22(3):269-75. PubMed ID: 10864063
    [No Abstract]   [Full Text] [Related]  

  • 28. Von Willebrand's disease.
    Hoyer LW
    Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
    [No Abstract]   [Full Text] [Related]  

  • 29. Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents.
    Caron C; Mazurier C; Goudemand J
    Br J Haematol; 2002 Jun; 117(3):716-8. PubMed ID: 12028048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry.
    Chiu PL; Bou-Assaf GM; Chhabra ES; Chambers MG; Peters RT; Kulman JD; Walz T
    Blood; 2015 Aug; 126(8):935-8. PubMed ID: 26065652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of von Willebrand disease.
    Mannucci PM
    Haemophilia; 1998 Jul; 4(4):661-4. PubMed ID: 9873811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
    Terraube V; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
    Yee A; Oleskie AN; Dosey AM; Kretz CA; Gildersleeve RD; Dutta S; Su M; Ginsburg D; Skiniotis G
    Blood; 2015 Aug; 126(8):939-42. PubMed ID: 26065653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current therapy in children and adolescents with von Willebrand disease.
    Buga-Corbu I; Arion C
    J Med Life; 2014 Jun; 7(2):264-9. PubMed ID: 25408737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemate P von Willebrand factor/factor VIII concentrate: 25 years of clinical experience.
    Schramm W
    Haemophilia; 2008 Nov; 14 Suppl 5():3-10. PubMed ID: 18786006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
    Stibbe J
    Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ultrapure factor VIII concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients].
    Canales Albendea MA; Villar Camacho A; Chamarro Merino G; Magallón Martínez M
    Sangre (Barc); 1998 Feb; 43(1):93-4. PubMed ID: 9577189
    [No Abstract]   [Full Text] [Related]  

  • 40. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
    López-Fernández MF; Blanco-López MJ; Castiñeira MP; Batlle J
    Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.